Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Oncology|November 9, 2022
The Activity of Novel BCR-ABL Small-Molecule Degraders Containing Pyrimidine Rings and Their Role in Overcoming Drug ResistanceXu Zhang, Linglan Tu, Haohuan Chai, et al.
Disease Markers|March 21, 2022
CDK Inhibition Reverses Acquired 5-Fluorouracil Resistance in Hepatocellular Carcinoma CellsYiyi Pu, Dongmei Yan, Linglan Tu, et al.
RSC Advances|March 7, 2024
AIE/AEE tripodal PEGyl-melphalan supramolecules and detection of trinitrophenol in waterZhenghua Zhang, Yonghe Zhang, Liyan Cheng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 23, 2024
Investigation of the mechanism of USP28-mediated IFITM3 elevation in BCR-ABL-dependent imatinib resistance in CMLZilin Li, Yiling Xi, Linglan Tu, et al.
British Journal of Cancer|April 6, 2026
Suppression of LRRC41-mediated oncogenicity in hepatocellular carcinoma via USP7-targeted small molecule inhibitorsYue Huang, Yiling Xi, Huizong Nie, et al.
Experimental Cell Research|April 13, 2025
USP28 knockdown and small molecule inhibitors promote KRT1 destabilization and sensitize hepatocellular carcinoma cells to sorafenibZilin Li, Yan Wang, Jiahui Hu, et al.
Cellular Signalling|April 17, 2025
EIF2B5 promotes malignant progression of hepatocellular carcinoma by activating the PI3K/AKT signaling pathway through targeting RPL6Yiling Xi, Yue Huang, Jiahui Hu, et al.
Cellular Signalling|February 6, 2024
The IGF2BP2-lncRNA TRPC7-AS1 axis promotes hepatocellular carcinoma cell proliferation and invasionXu Zhang, Zilin Li, Huizong Nie, et al.
Pageof 2